EpiVax enters partnership for COVID-19 vaccine fund

EPIVAX has entered into a partnership with the nonprofit GAIA Vaccine Foundation to create a fund for EpiVax's COVID-19 vaccine trials.
EPIVAX has entered into a partnership with the nonprofit GAIA Vaccine Foundation to create a fund for EpiVax's COVID-19 vaccine trials.
PROVIDENCE – EpiVax inc. on Tuesday announced a partnership with the nonprofit GAIA Vaccine Foundation to use crowdsourcing to raise funds for a COVID-19 vaccine candidate. EpiVax’s vaccine is tailored for health care workers, according to the company. EpiVax also pledged to make a free license available to qualifying developing countries, as part of the…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -